Legislation
-
SAHPRA to increase regulatory capacity with Africa CDC donation
SAHPRA is set to boost its vaccine oversight with a $750,000 equipment donation from Africa CDC. This move marks a major step in strengthening South Africa’s regulatory capacity and supporting Africa’s ambitious plans to grow local vaccine manufacturing. Find out how this could shape the continent’s health future.
-
Brenntag Specialties partners with Qualifyze to enhance pharma audit offering
Brenntag partners with Qualifyze to offer seamless, high-quality third-party pharma audits, making it easier for customers to meet tough regulatory requirements. Discover how this collaboration helps manufacturers overcome audit challenges and ensures compliance across the supply chain.
-
Eastern Cape Cannabis and Hemp Training Academy to unlock economic opportunities
Discover how the new Eastern Cape Cannabis and Hemp Training Academy is empowering locals with in-demand skills and unlocking fresh economic opportunities in the region. Find out how industry partnerships are driving growth and building a brighter future for communities across the Eastern Cape.
-
Cheeba and Training Force collaborate on hemp training opportunities
Cheeba Cannabis Training and Training Force have joined forces to offer industry-driven hemp training across South Africa, empowering individuals with practical skills and real job opportunities. Discover how this partnership is shaping careers and advancing the local hemp industry—learn more about the benefits and impact.
-
Afriplex cannabis footprint continues to expand
Afriplex expands its global cannabis reach with a new Canadian partnership to supply CBG Isolate internationally, driving innovation in cannabinoid therapies. Discover how this move strengthens Afriplex’s position as a leader in the evolving cannabis industry.
-
Bureau Veritas committed to growing intra-African trade
Discover how Bureau Veritas is driving safer, stronger trade across Africa by raising compliance standards and supporting AfCFTA goals. Learn how investments in laboratories and verification programmes are unlocking opportunities for quality, made-in-Africa products to reach new markets.
-
ImpiloVest emerges as a new cannabis giant
ImpiloVest is set to lead South Africa’s booming cannabis industry, aiming for a R1 billion turnover as the market rapidly expands. Discover how this Western Cape company plans to shape the future of holistic cannabis solutions in a sector poised for massive growth.
-
Decade-long campaign gives beauty a cruelty-free makeover
Celebrate a decade of progress as beauty brands and Humane Society International mark 10 years since the EU banned cosmetic animal testing—discover how this movement is inspiring countries worldwide to adopt cruelty-free beauty standards and what’s next for the global #BeCrueltyFree campaign.
-
Rolling blackouts set to cripple plastics industry
South Africa’s plastics industry is facing major setbacks as rolling blackouts disrupt critical manufacturing processes. With power cuts halting production and threatening jobs, industry leaders warn of severe long-term consequences unless urgent action is taken.
-
Aggregation is the future of intelligent supply chains
Don’t let the FDA’s DSCSA deadline catch you off guard. Discover how flexible aggregation and advanced serialisation software can streamline your compliance and safeguard your supply chain—find out what trusted experts recommend for smarter protection.
-
SAHPRA registers new long-acting HIV pre-exposure prophylaxis
South Africa has just approved Apretude, the first long-acting injectable to help prevent HIV infection. This breakthrough offers a highly effective, convenient option for those at higher risk—marking a turning point in local HIV prevention efforts. Read more about what this means for public health.
-
SAHPRA concludes backlog clearance project
SAHPRA has successfully cleared a years-long backlog of over 16,000 medicine applications, unlocking faster access to essential therapies in South Africa. Discover how this milestone marks a new era for safe, affordable healthcare and regulatory efficiency.
